Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 김무곤, 안창돈filedCritical김무곤
Priority to KR1019870004721ApriorityCriticalpatent/KR900000547B1/en
Publication of KR880013577ApublicationCriticalpatent/KR880013577A/en
Application grantedgrantedCritical
Publication of KR900000547B1publicationCriticalpatent/KR900000547B1/en
A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Abstract
내용 없음No content
Description
동물용 약품제형Veterinary Drug Formulations
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음Since this is an open matter, no full text was included.
Claims (3)
기재로서 유당, 백당, 포도당, 덱스트린에서 선택된 1이상의 당류와 동물용 약품 및 1이상의 방부제 결합제를 함유한 조성물을 직경 10내지 50cm가량의 블럭형상으로 성형제조한 동물용 약품제형.An animal pharmaceutical formulation made of a composition containing one or more sugars selected from lactose, white sugar, glucose, and dextrin as a base material, and an animal medicine and one or more preservative binders in a block shape having a diameter of about 10 to 50 cm.제1항에서 당류의 함량이 60%이상이고 제형의 강도가 10kg/cm2이상인 동물용 약품제형.The veterinary pharmaceutical formulation of claim 1, wherein the sugar content is 60% or more and the strength of the formulation is 10kg / cm 2 or more.제1또는 제2항의 약품제형을 투여하여 가축의 질병을 예방 또는 치료하는 방법.A method for preventing or treating a disease in a livestock by administering the pharmaceutical formulation of claim 1.※ 참고사항 : 최초출원내용에 의하여 공개하는 것임.※ Note: The disclosure is based on the initial application.
KR1019870004721A1987-05-141987-05-14Pharmaceutical formation for using animal
KR900000547B1
(en)
DRUG IMMUNE SUBSTITUTING ACTION ON THE BASIS OF CELLULAR SUSPENSION AND METHOD FOR TREATMENT OF THE ACQUIRED IMMUNODEFICIENCY SYNDROME (HIV INFECTION) USING THIS ANTID